公司概覽
業務類別 --
業務概覽 BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
公司地址 Warfvinges vag 35, Stockholm, SWE, SE-112 51
電話號碼 +46 86956930
傳真號碼 --
公司網頁 https://www.bioarctic.se
員工數量 131
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Gunilla Osswald Chief Executive Officer and President -- 22/04/2025
Mr. Anders Martin-Lof Chief Financial Officer -- 22/04/2025
 
董事會成員
董事會 職務 更新日期
Dr. Eugen Steiner Chairman of the Board 22/04/2025
Mr. Par Gellerfors Independent Director 22/04/2025
Mr. Mikael Smedeby Independent Director 22/04/2025
Mr. Lars Lannfelt Director 22/04/2025
Ms. Lotta Ljungqvist Independent Director 22/04/2025
Ms. Cecilia Marie Edstrom Independent Director 22/04/2025
Ms. Anna-Lena Engwall Independent Director 22/04/2025
 
所屬ETF (更新日期: 02/05/2026 04:55)
代號 名稱 佔比% 持有日期
WSMLiShares MSCI World Small-Cap ETF0.003%28/04/2026
TLTDFlexShares Mstar DevMks exUS FctTilt ETF0.002%29/04/2026
IBRNiShares Neuroscience and Healthcare ETF0.002%29/04/2026
SPEUState Street® SPDR® Portfolio Europe ETF0.002%29/04/2026
DFAXDimensional World ex US Core Eq 2 ETF0.002%27/04/2026
DXIVDimensional International Vector Eq ETF0.001%27/04/2026
TXUGThornburg International Growth ETF0.001%28/02/2026
FPXEFirst Trust IPOX Europe Equity Opps ETF0.0001%29/04/2026
FDTSFirst Trust DevMkts exUS SC AlphaDEX®ETF<0.000001%13/04/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF<0.000001%27/02/2026
GWXState Street® SPDR® S&P® Intl Sm Cp ETF<0.000001%22/09/2025
HSCZiShares Currency Hdgd MSCI EAFE SmCp ETF<0.000001%03/03/2026
  1   2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.